Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
1271 results about "Mastitis" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Infection of the breast tissue resulting in pain, swelling, warmth and redness.
Plasma-assisted disinfection of milking machines
Owner:WISCONSIN ALUMNI RES FOUND
Nursing bra with pocket
A nursing bra comprised of two cups with an outer pocket / flap in each cup for holding a thin circular heating / cooling device in place. This pocket is a full piece of fabric with an opening at the upper center portion of the garment that holds the heating / cooling device in place. The heating / cooling device provides relief from engorgement, plugged ducts, mastitis and other general nursing pain. There is also a rear panel comprised of two cups with openings in each cup for nursing a baby. The front and rear panel coexist, forming a supportive and comfortable bra. The removable front, outer panel is connected to the rear panel at the base, which allows for the upper portion of the front panel to be lowered allowing the nipple, and surrounding area of the woman's breast to be exposed for nursing.
Owner:MILLER LEE & ADA
Microfluidic chamber assembly for mastitis assay
InactiveUS20090233329A1Easy to doSmall volumeBioreactor/fermenter combinationsBiological substance pretreatmentsMammalWhite blood cell
The present invention relates to a device and method for the detection of mastitis or other disease from a body fluid of a mammal for example from cow's milk. The device and method relates to a wedge microfluidic chamber for using a minimal amount of fluid and being able to use the device to observe leukocytes in a mono-layer for the purpose of disease detection, cell counts or the like.
Owner:ADVANCED ANIMAL DIAGNOSTICS
Posterior breast massage unit
A method of milk extraction system may include massaging a posterior of a breast. Massaging and collecting milk may optionally be performed simultaneously. A posterior massager may also be used and / or mounted separately from a collection unit. In some embodiments the massager may be used to improve milk collection and / or alleviate breast ailments for example engorgement, plugged ducts, and / or mastitis. A collection flange may include an air inlet manifold, to mix air and milk. Optionally as air is drawn along a tube by a vacuum, milk may be entrained in the airstream and brought towards a collection vessel. The system may include automated tracking of milk production and / or consumption.
Owner:POSITIVE CARE
Method for improved breast milk feeding to reduce the risk of allergy
Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause and thereby the amount of TGF-beta-2 in the milk, thus resulting in reduced risk for the lactating mother to develop mastitis.
Owner:BIOGIA
Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
InactiveUS20080153894A1Effectively treat painMinimal to no irritationAntibacterial agentsBiocideCOX-2 inhibitorMastitis
A method is provided for treatment of an infective condition in an udder of a milk producing animal. The method comprises intramammary administration of an antibacterial agent in combination therapy with a selective COX-2 inhibitor in therapeutically effective amounts of each. Also provided is a pharmaceutical composition comprising an antibacterial agent and a selective COX-2 inhibitor, together with one or more excipients, in a dosage form suitable for intramammary administration to a milk producing animal.
Owner:PHARMACIA CORP
Plasma-assisted disinfection of milking machines
In a milking machine teat cup wherein an animal to be milked has its teat inserted into a teat cup liner during milking, a first electrode extends about or within at least a portion of the teat cup liner. To clean and / or disinfect the liner, a second electrode is inserted into the liner and the two electrodes are charged so as to generate plasma in any free space between the inserted second electrode and the interior surface of the liner. The generated plasma species destroy organisms that cause mastitis, and can additionally kill other unwanted organisms and / or perform cleaning of the liner's interior.
Owner:WISCONSIN ALUMNI RES FOUND
Peracetic teat dip
InactiveUS20070249712A1Reduce mastitisGood curative effectBiocideHydroxy compound active ingredientsAcetic acidMastitis
A teat dip formula is disclosed for use on dairy animals with the objective of reducing or preventing mastitis. The teat dip formula preferably includes up to about 2% of peracetic acid in solution made by mixing acetic acid, hydrogen peroxide, and from up to about 5% by weight of composition of a thickening agent. Other constituents of the formula may include effective amounts of a skin conditioning agent or agents, a surfactant or surfactants and urea. A method of preparing and applying the formula is disclosed.
Owner:GEA WESTFALIASURGE INC
Peracetic teat dip
InactiveUS20060177518A1Effective antimicrobialSafe to handle and notBiocideHydroxy compound active ingredientsAcetic acidMastitis
A teat dip formula is disclosed for use on dairy animals with the objective of reducing or preventing mastitis. The teat dip formula preferably includes up to about 5000 ppm of peracetic acid in solution made in situ by mixing acetic acid and hydrogen peroxide. Other constituents of the formula may include effective amounts of a skin conditioning agent or agents, a surfactant or surfactants and urea. A method of preparing and applying the formula is disclosed.
Owner:GEA WESTFALIASURGE INC
System for optimizing the production performance of a milk producing animal herd
InactiveUS6814025B2Increase productivityIncrease profitabilitySamplingCathetersLactate dehydrogenaseAgricultural science
Owner:LATTEC
Special gestation compound feed for sows at later stage of pregnancy and preparation method thereof
InactiveCN102919570AReduce the incidence of constipationReduce laborFood processingAnimal feeding stuffConstipationFetus
The invention discloses a special gestation compound feed for sows at later stage of pregnancy. The special gestation compound feed is prepared from the following raw materials: corn, bran, rice bran meal, DDGS (dried distiller grains with soluble), swelling soya dregs, swelling soybean flour, fermented soybean meal, compound sugar, mountain flour, calcium hydrogen phosphate, choline chloride, common salt, compound premix, L-lysine hydrochloride, L-threonine, acidifier, clostridium butyricum and yeast cell wall polysaccharides. The invention, starts from nutrition of the sows at the later stage of the pregnancy, gives consideration to the growth of fetuses and the physiological characteristics of the sows per se, designs daily ration with high protein, high amino acid and low energy, adds the compound sugar constituted by different monosaccharides and disaccharides, and can provide energy which can be utilized quickly and improve the birth weight and the uniformity of piglets; and by adding the clostridium butyricum and the yeast cell wall polysaccharides, the special gestation compound feed can improve the intestinal health of the sows, improve immunity, regulate intestinal peristalsis, reduce the constipation incidence of the sows, shorten the labor stage of the sows, reduce the incidence rate of mastitis and endometritis of the sows, and assist the sows in rapid postpartum recovery.
Owner:HUAIAN ZHENGCHANG FEED
Chinese herbal medicine feedstuff additive-summer quiet powder and preparation method as well as application thereof
InactiveCN101181011AReduce morbidityPrevents a decline in milk productionAntipyreticFood processingDiseaseTrichosanthes kirilowii
The invention discloses a Chinese traditional herbal medicine foodstuff additive, Xia'ansan, and a preparation method and applications thereof. The additive is made from astragalus root, Chinese angilica, tube of dwarf lilyturf, dried tangerine peel, green tangerine peel, vegetable sponge, dandelion, fructus forsythiae, radix bupleuri, honeysuckle vine, complete Trichosanthes kirilowii Maxim, Saponaria vaccaria, fructus liquidambaris, and liquorice. The preparation method of the invention is that: the 14 materials are air-cured and dried, dried at 60 DEG C, and then crushed and sifted by 100-mesh sifter, and finally subpackaged. The additive can be blended into the foodstuff for feeding cow, which has heat and stress resistance function to cows giving milk, thus enhancing milk yield. The additive can be used in a hot season for 30 to 45 days in a dosage of 150 to 200g per day for one cow, which can ensure that cow maintains a milk yield increased by more than 10% in 120 days, and can dramatically reduce the incidences of mastitis, endometritis and hoof disease.
Owner:JINLING INST OF TECH
Film-forming compositions for protecting animal skin
InactiveUS20050063926A1Simple compositionExtension of timeCosmetic preparationsPowder deliveryPolyether polyurethaneElastic Barrier
Improved film-forming skin protectant compositions are provided which are capable of forming a long-lasting elastic barrier film when applied to skin; the compositions have particular utility as barrier teat dips, for protecting cows against mastitis, especially during their susceptible non-lactating periods. The compositions include a film-forming component (preferably a mixture of polyether polyurethane and nitrocellulose) dispersed in a compatible carrier and further having a quantity of a tackifier resin incorporated therein in order to increase the time of adherence of the composition to skin, as compared with an otherwise identical composition without a tackifier resin. The compositions may also include a germicide (e.g., chlorhexidine diacetate), and a coloring dye.
Owner:DELAVAL HLDG AB
Systems and methods for predicting the outcome of a state of a subject
Systems and methods for improving the health and wellbeing of subjects in an industrial setting are disclosed. The systems may include a camera arranged so as to observe one or more features of a subject, and a processor, coupled to the camera, the processor configured to analyze one or more images obtained therefrom, to extract one or more features from the image(s) of the subject, and to analyze one or more of the features, or sub features nested therein to predict an outcome of a state of the subject. In particular the system may be configured to generate a diagnostic signal (e.g. an outcome, fever, mastitis, virus, bacterial infection, rut, etc.) based upon the analysis.
Owner:AGRICAM
Meloxicam in veterinary medicine
A veterinary pharmaceutical formulation containing meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more vehicles having analgesic efficacy for the treatment of inflammatory painful diseases, particularly for the treatment of mild or moderate mastitis cases. The treatment leads to an effective long lasting reduction of a hypersensitive state associated with inflammatory pain in mild or moderate mastitis cases, particularly chronic states thereof.
Owner:BOEHRINGER LNGELHEIM VETMEDICA GMBH
Method of treatment using antimicrobial composition
InactiveUS20110209228A1Growth inhibitionLess-expensive to produceAntibacterial agentsOrganic active ingredientsDiseaseMastitis
The present invention provides peptides and analogs and derivatives thereof having antimicrobial activity at least against Streptococcus uberis for the treatment of a range of infectious disease mastitis, otitis externa, clostridial intestinal disease and respiratory disease.
Owner:AGRI VICTORIA SERVICES PTY LTD
Biological feed at later period of pregnancy and lactation period of sows
InactiveCN103355531AIncrease feed intakeIncrease milk productionAnimal feeding stuffWeaningWeightlessness
The invention discloses a biological feed at the later period of pregnancy and the lactation period of sows. The feed comprises the following components in percentage: 68.60% of corns in northeastern part, 6.10% of bran, 13.97% of bean pulp, 3.00% of fermented bean pulp, 3.00% of fish meal in Zhejiang, 1.00% of phospholipid oil, 0.02% of probiotics, 0.05% of angel yeast, 1.46% of mountain flour, 0.62% of calcium hydrophosphate, 0.28% of edible salt, 0.02% of phytase, 0.02% of concentrated enzyme, 0.24% of65% lysine, 0.12% of choline chloride, 1.00% of premix, 0.5% of traditional Chinese medicine additives, wherein the components are totally 100%. According to the invention, according to the physiology and reproduction characteristics of the later period of pregnancy and lactation period of sows, the traditional Chinese medicine additives are added in the feed; the lactation yield of sows is improved; the breast milk nutrition is increased, and the aims of sufficient milk quantity of sows, no weightlessness, mastitis prevention as well as high piglet rate of survival, high weight in weaning, and less death in weaning stress and having diarrhea are achieved.
Owner:江苏华威农牧发展有限公司
Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates
The antimicrobial activity of bovine bactericidal / permeability-increasing protein (bBPI)-derived synthetic peptides against mastitis-causing Gram-negative bacteria was evaluated. Three peptides were synthesized with sequences corresponding to amino acids 65-99 (bBPI65-99), 142-169 (bBPI142-169), or the combination of amino acids 90-99 and 148-161 (bBPI90-99,148-161) of bBPI. The bBPI90-99,148-161 peptide demonstrated the widest spectrum of antimicrobial activity, with minimum inhibitory (MIC) and bactericidal (MBC) concentration values ranging from 16-64 μg / ml against Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp, and 64-128 μg / ml against Pseudomonas aeruginosa. None of the peptides exhibited any growth inhibitory effect on Serratia marcescens. The antimicrobial activity of bBPI90-99,148-161 was inhibited in milk, but preserved in serum. Finally, both bBPI142-169 and bBPI90-99,148-161 were demonstrated to completely neutralize LPS. The peptide bBPI90-99,148-161 is a potent neutralizer of the highly pro-inflammatory molecule bacterial LPS and has antimicrobial activity against a variety of Gram-negative bacteria.
Owner:US SEC AGRI
Method for diagnosis of, and determination of susceptibility to bovine mastitis
InactiveUS6979550B1Useful predictionAnimal cellsMicrobiological testing/measurementMastitisComputer science
Owner:QUIMBY FREDERICK W +1
Treatment Method
InactiveUS20110008361A1Effective treatmentGreat ease in applicationAntibacterial agentsPeptide/protein ingredientsPhysiologyMastitis
A treatment composition for treating or preventing bovine mastitis, the treatment composition characterised in that it includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk, or a milk derived substance.
Owner:DEC INT NZ LTD
Chinese medicinal herb feed additive for meat rabbits and application thereof
InactiveCN101595947APrevent predisposition to diseaseImprove securityAnimal feeding stuffBulbulHouttuynia
The invention discloses a Chinese medicinal herb feed additive for meat rabbits and application thereof. The additive comprises the following components: ordate houttuynia, magnolia officinalis, bitter orange, phellodendron, Chinese bulbul, liquorice, rhizoma atractylodis, medicated leaven, Chinese yam rhizome, hawthorn, muze, pilose asiabell root and refined mirabilite. The additive fully considers Chinese medicament compatibility principles of eighteen incompatible medicaments and nineteen medicaments of mutual antagonism according to physiological characteristics of the meat rabbits, ensures that pointed components are compatible with each other, then draw the strong points of others to offset own weakness and cooperate with each other, has good disease-preventing, disease-resistant, growth-promoting and fattening effects, and strengthens the disease resistance. The additive can prevent common diseases that the meat rabbits are susceptible to such as mastitis, constipation, abdominal distension and the like, improve the economic benefit of rabbit breeding, has no side effect, and cannot remain harmful substances; the additive can play a larger role by about 2 percent of consumption, and cannot cause the damage to the physiological functions of the meat rabbits; and the Chinese medicinal herb additive has the advantages of broad sources of raw materials, low cost, high safety and remarkable benefit, so the additive can be developed toward a higher level in meat rabbit breeding industry.
Owner:邹振可
Barrier film-forming germicidal composition for controlling mastitis
ActiveUS20070275070A1Overcome problemsImprove artAntibacterial agentsOrganic active ingredientsFood additiveMicrobial agent
A long-lasting persistent, uniform film-forming skin protecting germicidal composition provides a long-lasting persistent barrier film when applied to skin. The compositions have particular utility as barrier teat dips for protecting cows against mastitis. A barrier film-forming agent is selected from the modified or hydrolyzed polysaccharides, particularly a hydrolyzed or modified starch, such as dextrin and maltodextrin. The barrier film-forming agent is stably solubilized in a solvent that dries to form the long-lasting persistent uniform film over the animal skin. The compositions also contain antimicrobial agents that fight against microbes that manage to penetrate the protective barrier film. Particularly, advantageous is that all the materials used are safe food additive and cost effective over the traditional barrier film forming agents.
Owner:VALEN TECH +1
Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
A method and pharmaceutical composition for ceasing milk production, for inducing involution, or for treating infection in a mammary gland of a lactating animal is described. The method is effected by direct administration of calcium chelators to the gland, or upon administration of enzymes which cause production of chelators in situ. The invention can be used to change the physiologic state of a single mammary gland of a lactating animal without significantly affecting the physiologic state of other mammary glands of the same animal. Changes resulting from use of the invention may be either transient or long lasting. The invention is expected to have uses in commercial agriculture and human medicine.
Owner:THE STATE OF ISRAEL MINIST OF AGRI & RURAL DEV AGRI RES ORG ARO VOLCANI CENT
Microfluidic Chamber Assembly for Mastitis Assay
ActiveUS20140315242A1Easy to doSmall volumeSamplingMicrobiological testing/measurementDiseaseWhite blood cell
The present invention relates to a device and method for the detection of mastitis or other disease from a body fluid of a mammal for example from cow's milk. The device and method relates to a wedge microfluidic chamber for using a minimal amount of fluid and being able to use the device to observe leukocytes in a mono-layer for the purpose of disease detection, cell counts or the like.
Owner:ADVANCED ANIMAL DIAGNOSTICS
Composition and method of treating mastitis
InactiveUS20070077235A1Improve purification effectPromote sportsBiocidePeptide/protein ingredientsLyaseMastitis
A composition and method for treating bacterial infections by the use of an effective amount of at least one lytic specific for the bacteria causing specific. The lytic enzyme is genetically coded for by a bacteriophage which may be specific for said bacteria. The enzyme may be at least one lytic protein or peptides in a natural or modified form.
Owner:LOOMIS LAWRENCE +1
Mastitis detection
InactiveUS20050123948A1High viscosityBioreactor/fermenter combinationsBiological substance pretreatmentsMilk sampleMastitis
Method and apparatus for testing a milk for mastitis wherein the milk sample is admixed with a detergent under condition that increase the viscosity of the milk sample; the increased viscosity mixture is subjected to a further procedure for further increasing its viscosity; and the further increased viscosity mixture is then tested for an attribute of somatic cells, such as DNA. This determination is then used to establish if the cow from whom the milk came has mastitis.
Owner:LELY PATENT
Chinese traditional medicine for treating mammary glands hyperplasia
InactiveCN101229357ARapid flow of bloodAmphibian material medical ingredientsHeavy metal active ingredientsAdditive ingredientPoultice
The invention relates to a traditional Chinese medicine for curing mammary hyperplasia, which comprises oral administration Chinese traditional pills and external application plaster. The oral administration Chinese traditional pills comprise 23 Chinese herb medicines, while the external application plaster comprises 32 Chinese herb medicines. The ingredients of the traditional Chinese medicine formula is mixed compatibly and properly; the plaster and the oral administration pills of the invention can effectively cure the mammary hyperplasia caused by various reasons and has fast efficacy, short course of treatment, high cure rate and low cost. The traditional Chinese medicine of the invention has unique healing efficacy to breast adenofibroma, breast cancer, nipple discharge, mastalgia, mastitis, breast deformity, micromazia, osteomyelitis, femoral head necrosis, various sores, lymphoid tuberculosis and eye-mouth deviation.
Owner:胡永旺
Functional feed for preventing and treating mastitis in dairy cows and preparation method thereof
ActiveCN102550857AImprove digestibilityHigh nutrient concentrationFood processingAnimal feeding stuffMastitisRumen
The invention discloses a functional feed for preventing and treating mastitis in dairy cows and a preparation method of the feed. The functional feed contains the following raw materials in parts by weight: 0.2 to 0.5 part of probiotics, 40 to 60 parts of corn, 8 to 15 parts of wheat bran, 5 to 15 parts of dehulled soybean meal, 5 to 10 parts of corn distillers'grains, 5 to 15 parts of dephenolized cotton meal, 4 to 10 parts of cotton meal, 2 to 5 parts of shorts, 3 to 4 parts of calcium hydrogen phosphate, 1.5 to 2 parts of shorts and stone powders, 2 to 3 parts of rumen fat powders, 1.0 to1.5 parts of baking soda, 0.5 to 1.0 parts of magnesium oxide, 0.3 to 0.8 part of sodium chloride, 1 to 2 parts of molasses, 1 to 1.5 parts of premix for lactating cows and 0.5 to 1 part of sodium sulfate. The results of the study in dairy cows show that the functional feed can reduce the number of somatic cells of dairy cows and can effectively prevent the incidence and development of mastitis in dairy cows.
Owner:BEIJING JIUZHOU DADI BIOLOGICAL TECH GRP
Topical veterinary compositions and methods for the treatment and prevention of infection
ActiveUS20050031705A1Reduce stimulationGood moisturizing effectBiocidePeptide/protein ingredientsMastitisPhospholipid
The present invention provides compositions and methods for the treatment of infection in a subject. More particularly, the invention provides a therapy for the treatment or prevention of mammary infections, such as bovine mastitis, comprising the topical administration to a subject of an anti-microbial agent and a phospholipid-containing skin conditioner.
Owner:KO MFG
Use of meloxicam formulations in veterinary medicine
The invention is directed to the use of a formulation containing meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base, one or more vehicles and one or more suitable additives for preparing a veterinary medical composition for intramammary treatment of inflammatory diseases in mammals, particularly mastitis. The intramammary administration leads to an effective concentration in the target tissue, which is achieved very quickly.
Owner:BOEHRINGER LNGELHEIM VETMEDICA GMBH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com